(Q40727618)

23 September 2017

1 reference

title

New antithrombotic strategies for resistant thrombotic processes (English)

1 reference

23 September 2017

Harker LA

1

1 reference

23 September 2017

1 January 1994

1 reference

The Journal of Clinical Pharmacology

23 September 2017

1 reference

23 September 2017

34

1 reference

23 September 2017

1

1 reference

23 September 2017

3-16

1 reference

Molecular and cellular biology of blood coagulation

23 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Platelets and thrombolytic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

A recombinant chimeric plasminogen activator with high affinity for fibrin has increased thrombolytic potency in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Serpin-resistant mutants of human tissue-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

GPIIb-IIIa: the responsive integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Integrins: versatility, modulation, and signaling in cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Platelet membrane glycoproteins: functions in cellular interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Role of platelet membrane glycoproteins and von Willebrand factor in adhesion of platelets to subendothelium and collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Arginine-glycine-aspartic acid- and fibrinogen gamma-chain carboxyterminal peptides inhibit platelet adherence to arterial subendothelium at high wall shear rates. An effect dissociable from interference with adhesive protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Acceleration of recombinant tissue-type plasminogen activator-induced thrombolysis and prevention of reocclusion by the combination of heparin and the Arg-Gly-Asp-containing peptide bitistatin in a canine model of coronary thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Agkistrodon piscivorus piscivorus platelet aggregation inhibitor: a potent inhibitor of platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Domains specifying thrombin–receptor interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Characterization of a functional thrombin receptor. Issues and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

The structure of a complex of recombinant hirudin and human alpha-thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Human alpha-thrombin binding to nonpolymerized fibrin-Sepharose: evidence for an anionic binding region

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

A catalytic role for heparin. Evidence for a ternary complex of heparin cofactor thrombin and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Kinetics of the inhibition of thrombin by hirudin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Selective inhibition by a synthetic hirudin peptide of fibrin-dependent thrombosis in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Heparin-resistant thrombus formation by endovascular stents in baboons. Interruption by a synthetic antithrombin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Purification and characterization of recombinant antistasin: a leech-derived inhibitor of coagulation factor Xa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Dietary fish oil accelerates the response to coronary thrombolysis with tissue-type plasminogen activator. Evidence for a modest platelet inhibitory effect in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Haemostatic function and platelet polyunsaturated fatty acids in Eskimos

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Food use and health effects of soybean and sunflower oils

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Fatty acid distribution in systems modeling the normal and diabetic human circulation. A 13C nuclear magnetic resonance study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Platelet procoagulant activity: physiological significance and mechanisms of exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

Regulation of platelet-derived growth factor ligand and receptor gene expression by alpha-thrombin in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03960.X

10.1002/J.1552-4604.1994.TB03960.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

8132848